About Gennex Laboratories
Gennex Laboratories is a company based in Hyderabad (India) founded in 1995. The company has 115 employees as of March 31, 2024. Gennex Laboratories offers products and services including Phenazopyridine Hcl, Methocarbamol, Mephenesin, Melitracen Hcl, and Guaifenesin. Gennex Laboratories operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Hyderabad, India
- Employees 115 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gennex Laboratories Limited
-
Annual Revenue
$16.15 M (USD)59.03as on Mar 31, 2025
-
Net Profit
$2.12 M (USD)37.55as on Mar 31, 2025
-
EBITDA
$1.98 M (USD)-2.53as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
115
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Gennex Laboratories
Gennex Laboratories is a publicly listed company on the BSE with ticker symbol GENNEX in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Gennex Laboratories
Gennex Laboratories offers a comprehensive portfolio of products and services, including Phenazopyridine Hcl, Methocarbamol, Mephenesin, Melitracen Hcl, and Guaifenesin.
Active ingredient used for urinary tract pain relief.
Muscle relaxant for treating musculoskeletal conditions.
Skeletal muscle relaxant for medical applications.
Antidepressant and anxiolytic compound.
Expectorant to relieve cough and chest congestion.
Antipsychotic for mental health treatments.
Funding Insights of Gennex Laboratories
Detailed funding history for Gennex Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gennex Laboratories
Investment portfolio details for Gennex Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gennex Laboratories
Detailed financials for Gennex Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gennex Laboratories Comparisons
Peer comparison for Gennex Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gennex Laboratories
Gennex Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Gennex Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gennex Laboratories
Complete news archive for Gennex Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gennex Laboratories
Gennex Laboratories was founded in 1995.
Gennex Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2024, the latest employee count at Gennex Laboratories is 115.
Annual revenue of Gennex Laboratories is $16.15M as on Mar 31, 2025.
Gennex Laboratories was established in 1995 in Hyderabad, India, within the pharmaceutical sector. APIs are produced, marketed, and exported to clients including major industry players in India and abroad. Operations focus on a product portfolio that includes expectorants, muscle relaxants, analgesics, and anti-fungals. Primary markets are served in Latin America, the Mid East, and Central Asia.
Gennex Laboratories's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Gennex Laboratories offers Phenazopyridine Hcl, Methocarbamol, Mephenesin, Melitracen Hcl, and 2 more products and services.
Yes, Gennex Laboratories is publicly traded on BSE under the ticker symbol GENNEX.
The ticker symbol of Gennex Laboratories is GENNEX on BSE.